These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4948090)

  • 21. Progress towards development of immunoassays for detection of Mycobacterium leprae infection, employing 35kDa antigen: an update.
    Parkash O
    Lepr Rev; 2002 Mar; 73(1):9-19. PubMed ID: 11969136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical applications of recent advances in immunology of leprosy.
    Talwar GP; Moudgil KD; Munshi A
    Indian J Lepr; 1987; 59(2):119-26. PubMed ID: 3309081
    [No Abstract]   [Full Text] [Related]  

  • 23. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of diversified antigens for detection of Mycobacterium leprae antibodies from leprosy patients and contacts.
    Singh NB; Bhatnagar S; Choudhary A; Gupta HP; Kaul SM
    Indian J Exp Biol; 1994 Jul; 32(7):478-81. PubMed ID: 7959924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
    Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
    Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serodiagnostic monitoring of leprosy].
    Diachina MN
    Probl Tuberk Bolezn Legk; 2003; (11):32-9. PubMed ID: 14689796
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
    Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
    FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of serological tests to leprosy control.
    Klatser PR; Cho SN; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S63-6; discussion S66-7. PubMed ID: 9030128
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment: the serodiagnosis of leprosy.
    González AB; González-Albreu E
    Lepr Rev; 1994 Jun; 65(2):147-9. PubMed ID: 7968190
    [No Abstract]   [Full Text] [Related]  

  • 32. Bangkok Workshop on Leprosy Research. Immunodiagnostics, including skin tests.
    Brennan PJ; Cho SN; Klatser PR
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S58-62. PubMed ID: 9030127
    [No Abstract]   [Full Text] [Related]  

  • 33. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
    Hussain R; Dockrell HM; Chiang TJ
    Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of subcellular components of BCG for studying host-Mycobacterium interaction in relation to leprosy.
    Das PK; Ibrahim AA; Binkhuysen F; Thi Hué P; Qui TH; Rangarajan R; Ruitenberg EJ
    Ann Immunol (Paris); 1982; 133D(1):41-59. PubMed ID: 6760793
    [No Abstract]   [Full Text] [Related]  

  • 36. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic evaluation of mycobacterium vaccae in relation to Mycobacterium leprae.
    Navalkar RG; Chaparas SD; Lakshiminarayana CK; Kanchana MV
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):388-96. PubMed ID: 6782031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitivity and specificity of fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection by Mycobacterium leprae].
    Ji BH
    Zhonghua Yi Xue Za Zhi; 1984 Jun; 64(6):364-8. PubMed ID: 6437637
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.